Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells (Q38843995)

6 September 2017

title

Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells (English)

1 reference

6 September 2017

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270885 AND SRC:MED&resulttype=core&format=json

31 May 2020

George Aslanidi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270885 AND SRC:MED&resulttype=core&format=json

31 May 2020

author name string

R Sayroo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270885 AND SRC:MED&resulttype=core&format=json

31 May 2020

D Nolasco

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270885 AND SRC:MED&resulttype=core&format=json

31 May 2020

Z Yin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270885 AND SRC:MED&resulttype=core&format=json

31 May 2020

Y Colon-Cortes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270885 AND SRC:MED&resulttype=core&format=json

31 May 2020

M Pandya

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270885 AND SRC:MED&resulttype=core&format=json

31 May 2020

publication date

13 August 2015

1 reference

6 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270885 AND SRC:MED&resulttype=core&format=json

31 May 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270885 AND SRC:MED&resulttype=core&format=json

31 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270885 AND SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

18-25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270885 AND SRC:MED&resulttype=core&format=json

31 May 2020

cites work

Global cancer statistics

1 reference

Vectors selected from adeno-associated viral display peptide libraries for leukemia cell-targeted cytotoxic gene therapy

21 January 2018

1 reference

Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors

21 January 2018

1 reference

Directed evolution of novel adeno-associated viruses for therapeutic gene delivery.

21 January 2018

1 reference

Vector design Tour de Force: integrating combinatorial and rational approaches to derive novel adeno-associated virus variants

21 January 2018

1 reference

The AAV vector toolkit: poised at the clinical crossroads

21 January 2018

1 reference

Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results

21 January 2018

1 reference

rAAV Human Trial Experience

21 January 2018

1 reference

The parvovirus capsid odyssey: from the cell surface to the nucleus

21 January 2018

1 reference

Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism

21 January 2018

1 reference

Tailoring the AAV vector capsid for gene therapy.

21 January 2018

1 reference

Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus

21 January 2018

1 reference

Random Insertion of mCherry Into VP3 Domain of Adeno-associated Virus Yields Fluorescent Capsids With no Loss of Infectivity

21 January 2018

1 reference

Plectin-1 Targeted AAV Vector for the Molecular Imaging of Pancreatic Cancer

21 January 2018

1 reference

RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism

21 January 2018

1 reference

Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids

21 January 2018

1 reference

Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold?

21 January 2018

1 reference

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism

21 January 2018

1 reference

Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes

21 January 2018

1 reference

Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses

21 January 2018

1 reference

Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization

21 January 2018

1 reference

Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors

21 January 2018

1 reference

Rationally designed capsid and transgene cassette of AAV6 vectors for dendritic cell-based cancer immunotherapy.

21 January 2018

1 reference

High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors

21 January 2018

1 reference

High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines.

21 January 2018

1 reference

Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo.

21 January 2018

1 reference

High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors.

21 January 2018

1 reference

Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression

21 January 2018

1 reference

Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model

21 January 2018

1 reference

Oncolytic viruses: From bench to bedside with a focus on safety

21 January 2018

1 reference

Oncolytic viruses: perspectives on clinical development

21 January 2018

1 reference

Oncolytic viruses and their application to cancer immunotherapy

21 January 2018

1 reference

Clinical development directions in oncolytic viral therapy

21 January 2018

1 reference

Suicide gene therapy in cancer: where do we stand now?

21 January 2018

1 reference

Cytotoxic genes from traditional Chinese medicine inhibit tumor growth both in vitro and in vivo

21 January 2018

1 reference

Gene therapy clinical trials worldwide to 2012 - an update.

21 January 2018

1 reference

Adeno-associated virus type 2 infection activates caspase dependent and independent apoptosis in multiple breast cancer lines but not in normal mammary epithelial cells

21 January 2018

1 reference

Selection and evaluation of clinically relevant AAV variants in a xenograft liver model

21 January 2018

1 reference

Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance.

21 January 2018

1 reference

A dual role of EGFR protein tyrosine kinase signaling in ubiquitination of AAV2 capsids and viral second-strand DNA synthesis

21 January 2018

1 reference

Structural Characterization of the Dual Glycan Binding Adeno-Associated Virus Serotype 6

21 January 2018

1 reference

Structure–function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6)

21 January 2018

1 reference

Optimized transduction of human monocyte-derived dendritic cells by recombinant adeno-associated virus serotype 6.

21 January 2018

1 reference

Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle

21 January 2018

1 reference

AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells

21 January 2018

1 reference

Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors

21 January 2018

1 reference

Pristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivo

21 January 2018

1 reference

High-efficiency transduction of liver cancer cells by recombinant adeno-associated virus serotype 3 vectors.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26270885

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26270885